An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Abroad (travel likely)RecruitingPHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Colorectal Cancer · CRC (Colorectal Cancer) · Cancer Cachexia
Locations
- NGM Clinical Study Site, Los Angeles, California, United States
- NGM Clinical Study Site, Los Angeles, California, United States
- NGM Clinical Study Site, Santa Rosa, California, United States
- NGM Clinical Study Site, Margate, Florida, United States
- NGM Clinical Study Site, Baltimore, Maryland, United States
- NGM Clinical Study Site, New York, New York, United States
- NGM Clinical Study Site, Toledo, Ohio, United States
- NGM Clinical Study Site, Youngstown, Ohio, United States
- NGM Clinical Study Site, Dallas, Texas, United States
- NGM Clinical Study Site, Kingwood, Texas, United States
- NGM Clinical Study Site, Laredo, Texas, United States
- NGM Clinical Study Site, Richmond, Virginia, United States
- NGM Clinical Study Site, Appleton, Wisconsin, United States
- NGM Clinical Study Site, Tbilisi, Georgia
- NGM Clinical Study Site, Tbilisi, Georgia
- NGM Clinical Study Site, Tbilisi, Georgia
- NGM Clinical Study Site, Tbilisi, Georgia
- NGM Clinical Study Site, Tbilisi, Georgia
- NGM Clinical Study Site, Goyang, South Korea
- NGM Clinical Study Site, Goyang, South Korea
- NGM Clinical Study Site, Incheon, South Korea
- NGM Clinical Study Site, Seoul, South Korea
- NGM Clinical Study Site, Seoul, South Korea
- NGM Clinical Study Site, Seoul, South Korea
- NGM Clinical Study Site, Suwon, South Korea
- NGM Clinical Study Site, Taichung, Taiwan
- NGM Clinical Study Site, Taipei, Taiwan
- NGM Clinical Study Site, Taoyuan District, Taiwan